Morning Alert: LiveDeal(NASDAQ:LIVE), Freeport-McMoRan Inc. (NYSE:FCX), Boise Cascade Company (NYSE:BCC), Oragenics Inc. (NYSEMKT:OGEN), Transcat Inc. (NASDAQ:TRNS)


LiveDeal Inc. (NASDAQ:LIVE) announces that it is launching a fully integrated national advertising campaign across multiple channels, including television, radio, digital display and out-of-home platforms to expand its reach among restaurants across the United States.LiveDeal, Inc. (NASDAQ:LIVE) in last trading activity advanced 0.68% to close at $2.97. Company weekly performance is -4.19% while its quarterly performance stands at -23.06%. LiveDeal, Inc. (NASDAQ:LIVE) is -75.13% away from its 52 week high.

Freeport-McMoRan Inc (NYSE:FCX) is facing an expected challenge in Indonesia, and the company has been forced to lower its production outlook. Labor unrest has erupted in the company’s largest copper and gold mine in Indonesia following deaths of some workers. On last trading day Freeport-McMoRan Inc. (NYSE:FCX) moved down -3.14% to close at $28.08. Its volatility for the week is 2.41% while volatility for the month is 2.69%. FCX’s sales growth for past 5 years was 3.30% and its EPS growth for past 5 years was 16.80%. Freeport-McMoRan Inc. (NYSE:FCX) monthly performance is -11.03%.

Boise Cascade Company (NYSE:BCC)’s latest quarterly earnings report indicates $32.3 million in profits and $983.3 million in sales. Both figures are increases from the previous quarter and from the same quarter in 2013. Sales increased 12 percent from the previous year, while profits increased 104 percent. On last trading day Boise Cascade Company (NYSE:BCC) advanced 1.70% to close at $35.24. Its volatility for the week is 4.65% while volatility for the month is 3.86%. BCC’s sales growth for past 5 years was 1.90% and its EPS growth for past 5 years was 0.00%. Boise Cascade Company (NYSE:BCC) monthly performance is 19.70%.

Florida-based biopharmaceutical company Oragenics Inc. (NYSEMKT:OGEN) has announced that Dr. John Bonfiglio resigned as Chief Executive Officer President and director of Oragenics Inc. to pursue other opportunities. Oragenics Inc. (NYSEMKT:OGEN) has 2.30% insider ownership while its institutional ownership stands at 41.10%. In last trading activity company’s stock closed at $0.86.

Transcat Inc. (NASDAQ:TRNS) reported an 11 percent increase in net income along with record sales in its fiscal second quarter. The company posted net income of $859,000, or 12 cents a diluted share, in the quarter ending Sep. 27 compared with $771,000, or 10 cents a diluted share, a year ago. On Thursday shares of Transcat Inc. (NASDAQ:TRNS) closed at $10.05. Company’s sales growth for last 5 years was 9.50%.


Leave a Reply

Your email address will not be published. Required fields are marked *